These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 32356548)

  • 1. QSAR without borders.
    Muratov EN; Bajorath J; Sheridan RP; Tetko IV; Filimonov D; Poroikov V; Oprea TI; Baskin II; Varnek A; Roitberg A; Isayev O; Curtarolo S; Fourches D; Cohen Y; Aspuru-Guzik A; Winkler DA; Agrafiotis D; Cherkasov A; Tropsha A
    Chem Soc Rev; 2020 Jun; 49(11):3525-3564. PubMed ID: 32356548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR modeling: where have you been? Where are you going to?
    Cherkasov A; Muratov EN; Fourches D; Varnek A; Baskin II; Cronin M; Dearden J; Gramatica P; Martin YC; Todeschini R; Consonni V; Kuz'min VE; Cramer R; Benigni R; Yang C; Rathman J; Terfloth L; Gasteiger J; Richard A; Tropsha A
    J Med Chem; 2014 Jun; 57(12):4977-5010. PubMed ID: 24351051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current approaches for choosing feature selection and learning algorithms in quantitative structure-activity relationships (QSAR).
    Khan PM; Roy K
    Expert Opin Drug Discov; 2018 Dec; 13(12):1075-1089. PubMed ID: 30372648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4D- quantitative structure-activity relationship modeling: making a comeback.
    Fourches D; Ash J
    Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical descriptors for the prediction of property, bioactivity, and toxicity of chemicals from their structure: a chemical-cum-biochemical approach.
    Basak SC
    Curr Comput Aided Drug Des; 2013 Dec; 9(4):449-62. PubMed ID: 24138422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR.
    Tropsha A; Isayev O; Varnek A; Schneider G; Cherkasov A
    Nat Rev Drug Discov; 2024 Feb; 23(2):141-155. PubMed ID: 38066301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
    Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR: What Else?
    Gini G
    Methods Mol Biol; 2018; 1800():79-105. PubMed ID: 29934888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from Multiple Classifier Systems: Perspectives for Improving Decision Making of QSAR Models in Medicinal Chemistry.
    Pham-The H; Nam NH; Nga DV; Hai DT; Dieguez-Santana K; Marrero-Poncee Y; Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H
    Curr Top Med Chem; 2018 Feb; 17(30):3269-3288. PubMed ID: 29231145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR and the role of luck in research.
    Hansch C
    Farmaco; 2003 Sep; 58(9):621-3. PubMed ID: 14562802
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
    Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
    J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Deep Learning-Based Quantitative Structure-Activity Relationship System Construct Prediction Model of Agonist and Antagonist with High Performance.
    Matsuzaka Y; Uesawa Y
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the domain of applicability for machine learning QSAR models: a study on aqueous solubility of drug discovery molecules.
    Schroeter TS; Schwaighofer A; Mika S; Ter Laak A; Suelzle D; Ganzer U; Heinrich N; Müller KR
    J Comput Aided Mol Des; 2007 Dec; 21(12):651-64. PubMed ID: 18060505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of mutual information, genetic algorithm and SVR for feature selection in QSAR regression.
    Fang J; Tai D
    Curr Drug Discov Technol; 2011 Jun; 8(2):107-11. PubMed ID: 21513488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
    Dobchev D; Karelson M
    Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the domain of applicability for machine learning QSAR models: a study on aqueous solubility of drug discovery molecules.
    Schroeter TS; Schwaighofer A; Mika S; Ter Laak A; Suelzle D; Ganzer U; Heinrich N; Müller KR
    J Comput Aided Mol Des; 2007 Sep; 21(9):485-98. PubMed ID: 17632688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling liver-related adverse effects of drugs using knearest neighbor quantitative structure-activity relationship method.
    Rodgers AD; Zhu H; Fourches D; Rusyn I; Tropsha A
    Chem Res Toxicol; 2010 Apr; 23(4):724-32. PubMed ID: 20192250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.